- Division of Neuroscience, Development and Aging – DNDA
- Brain Disorders and Clinical Neuroscience – BDCN
- Study Section:
- Clinical Neuroimmunology and Brain Tumors – CNBT
Dr. Wei-Qin Zhao is the Scientific Review Officer for CSR’s Clinical Neuroimmunology and Brain Tumors (CNBT) study section.
She received her medical training from Sun Yat-sen University of Medical Sciences in China, and a Ph.D. in neurobiology from LaTrobe University in Australia. She worked as a postdoctoral fellow in LaTrobe University, a lecturer in Monash University, Australia, and a Visiting Fellow in National Institute of Neurological Disorders and Stroke, NIH. She then took a position of associate professor in Blanchette Rockefeller Neurosciences Institute, followed by a Visiting Scholar in Northwestern University. Prior to joining CSR in 2011, she was a senior research biologist at Merck Research Laboratories. Dr Zhao’s research interests are in molecular/cellular mechanisms underlying learning and memory, and drug discovery for cognitive disorders such as Alzheimer’s disease and schizophrenia.